GIMV (EBR:GIMB) Gimv participates in a $92M Series A financing round at Kivu Bioscience to advance next-gen antibody-drug conjugates
Transparency directive : regulatory news
28/10/2024 17:45
source : webdisclosure.com
GIMV's latest news
13/01/2025 17:45
23/12/2024 17:45
18/12/2024 07:30
04/12/2024 07:30
02/12/2024 07:30
21/11/2024 06:58
20/11/2024 07:45
28/10/2024 17:45
16/10/2024 07:45
19/09/2024 17:45
Other stories
15/01/2025 01:34
15/01/2025 08:04
14/01/2025 21:59
15/01/2025 07:05
15/01/2025 07:12
15/01/2025 03:51
15/01/2025 07:07
15/01/2025 08:01
14/01/2025 22:24
14/01/2025 19:32
15/01/2025 08:33
14/01/2025 18:46
14/01/2025 19:55
14/01/2025 21:01
15/01/2025 08:00
15/01/2025 05:29
15/01/2025 01:01
15/01/2025 08:25
14/01/2025 20:12
14/01/2025 17:30
15/01/2025 01:17
15/01/2025 07:11
14/01/2025 23:37
14/01/2025 16:56
15/01/2025 07:00
14/01/2025 21:43
15/01/2025 08:07
15/01/2025 08:44
15/01/2025 02:55
15/01/2025 07:33
15/01/2025 07:38
14/01/2025 16:57
14/01/2025 10:24
14/01/2025 08:36
15/01/2025 00:32
14/01/2025 18:32
13/01/2025 13:52
14/01/2025 07:35